Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,310.00
+210.00 (2.59%)
At close: Jun 25, 2025, 3:30 PM KST
61.57%
Market Cap 192.09B
Revenue (ttm) 8.27B
Net Income (ttm) -1.28B
Shares Out 23.89M
EPS (ttm) -53.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 269,509
Average Volume 181,526
Open 8,100.00
Previous Close 8,100.00
Day's Range 7,990.00 - 8,450.00
52-Week Range 3,903.33 - 13,200.00
Beta 0.78
RSI 28.65
Earnings Date n/a

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 71
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.